Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Defense Mechanism Against Infection01:26

Defense Mechanism Against Infection

Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
Vaccinations01:51

Vaccinations

Overview
Active versus Passive Immunity01:31

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Individual contributions of exotoxins S and T on internalized <i>P. aeruginosa</i>.

Infection and immunity·2026
Same author

A versatile dual-color bacterial reporter system highlights two distinct <i>Pseudomonas aeruginosa</i> type 3 secretion system intracellular populations.

Applied and environmental microbiology·2026
Same author

Manufacture of the first FDA-approved batches of 900 kilodalton crystalline type a botulinum toxin for clinical use: a personal remembrance.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same author

Transcriptional regulation of the pneumococcal capsule can dictate serotype-specific infection.

Nature communications·2026
Same author

Enteric botulinum neurotoxins facilitate infection by <i>Salmonella</i> and <i>Shigella</i>.

Science advances·2026
Same author

Korean botulinum toxins.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Related Experiment Video

Updated: May 11, 2026

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
12:25

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

Enhancing the protective immune response against botulism.

Amanda Przedpelski1, William H Tepp, Abby R Kroken

  • 1Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Infection and Immunity
|May 15, 2013
PubMed
Summary

A new botulinum neurotoxin type A (BoNT/A) vaccine using a modified host cell receptor binding (HCR) subunit showed enhanced protection. Removing receptor binding capacity improved vaccine potency and reduced potential toxicity.

More Related Videos

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
10:30

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

Related Experiment Videos

Last Updated: May 11, 2026

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
12:25

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
10:30

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

Area of Science:

  • Microbiology
  • Immunology
  • Vaccine Development

Background:

  • The discontinuation of the pentavalent botulinum toxoid vaccine necessitates new vaccine strategies.
  • Botulinum neurotoxins (BoNTs) are key virulence factors, with distinct domains for catalysis, translocation, and host receptor binding (HCR).
  • Recombinant HCR subunits are being explored for next-generation BoNT vaccines.

Purpose of the Study:

  • To design and evaluate a novel HCR subunit vaccine against BoNT/A by modifying the ganglioside binding pocket.
  • To assess the immunogenicity and protective efficacy of the modified HCR/A vaccine in a mouse model.

Main Methods:

  • A BoNT/A HCR subunit vaccine (HCR/A(W1266A)) was engineered with a mutation to abolish ganglioside binding.
  • Structural analysis confirmed the mutation did not alter overall HCR/A structure.
  • Vaccine efficacy was tested in mice using high and low doses, followed by BoNT/A challenge.

Main Results:

  • Both HCR/A and HCR/A(W1266A) provided protection at high vaccine doses.
  • HCR/A(W1266A) demonstrated superior protection compared to HCR/A at low vaccine doses.
  • Antibody titers correlated with protection, but blocking of HCR/A entry was more efficient with HCR/A-vaccinated sera.

Conclusions:

  • Abolishing receptor binding capacity of the HCR subunit enhances vaccine potency against BoNT/A.
  • This strategy offers a promising approach for developing safer and more effective botulism vaccines.
  • Vaccines lacking receptor binding may have reduced off-target toxicity.